Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07450209 · ClinicalTrials.gov registry record · Phase 2
COVID-19 Rapid Test-to-Treat With African American Churches (Faithful Response II)
A Phase 2 study of COVID-19 Testing Behaviors, sponsored by University of Missouri, Kansas City.
- Active
- Registry status
- Phase 2
- Development phase
- 900
- Enrollment target
- 1
- Study location
NCT07450209 is a Phase 2 study of COVID-19 Testing Behaviors that is active but no longer recruiting, run by University of Missouri, Kansas City. The registered enrollment target is 900 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07450209, a Phase 2 study of COVID-19 Testing Behaviors, is active but no longer recruiting, sponsored by University of Missouri, Kansas City.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 900 participants
- Enrollment target
- 1
- Study location
Study Summary
This 2-arm clustered, randomized community trial will test a multilevel, religiously-tailored COVID-19 rapid, self-testing and treatment intervention against a nontailored, education condition on uptake of COVID-19 rapid testing with 900 adult African American church members and community members using outreach ministry services from 12 churches at 6 months. Rapid COVID-19 self-testing and contact tracing (beliefs and practices), and use of linkage to care services (e.g., referrals to treatment, health insurance, medical home/appointments, community resources) will also be examined. Findings from this study could provide a scalable model for feasible, accessible and acceptable COVID-19 rapid, self-testing (with rapid linkage to treatment and health/community resources) in public (churches and their affiliate settings and organizations), home, and health provider spaces by equipping African American churches with culturally-appropriate, easy-to-use rapid test kits, health department support, and tailored COVID-19 test-to-treat education and promotion tools.
Conditions Studied
Interventions
- BEHAVIORAL COVID-19 rapid test-to-treat
- BEHAVIORAL Standard COVID19 education control arm
Study Locations (1)
Missouri
- School of Medicine - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2024-05-15 |
| Est. Completion | 2026-03-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07450209
The ClinicalTrials.gov registry entry for NCT07450209 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri, Kansas City, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with COVID-19 Testing Behaviors appearing as the primary indexed condition, and to 2 interventions - of which COVID-19 rapid test-to-treat is the first listed.
NCT07450209 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT07450209 about?
NCT07450209 is a clinical study titled "COVID-19 Rapid Test-to-Treat With African American Churches (Faithful Response II)". This 2-arm clustered, randomized community trial will test a multilevel, religiously-tailored COVID-19 rapid, self-testing and treatment intervention against a nontailored, education condition on uptake of COVID-19 rapid testing with 900 adult African American church members and community members us...
What is the current status of trial NCT07450209?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 900 participants. The study started on 2024-05-15. Estimated completion is 2026-03-01.
What conditions does trial NCT07450209 study?
This clinical trial studies the following conditions: COVID-19 Testing Behaviors.
What interventions are being tested in trial NCT07450209?
The interventions under investigation include: COVID-19 rapid test-to-treat (BEHAVIORAL), Standard COVID19 education control arm (BEHAVIORAL).
Who is sponsoring clinical trial NCT07450209?
This trial is sponsored by University of Missouri, Kansas City, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07450209 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.